--- title: "YZYBIO-B: Wang Tao elected as employee representative supervisor" type: "News" locale: "en" url: "https://longbridge.com/en/news/257868601.md" description: "According to the Zhitong Finance APP, YZYBIO-B announced that Mr. Zhang Jing resigned from his position as employee representative supervisor of the company for personal career development reasons, effective September 18, 2025. Dr. Wang Tao, Executive Director of the company's R&D Platform Department, was democratically elected as the employee representative supervisor of the second supervisory board on September 18, 2025. Dr. Wang Tao's term will be effective from September 18, 2025, and will expire at the end of the second supervisory board" datetime: "2025-09-18T08:53:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/257868601.md) - [en](https://longbridge.com/en/news/257868601.md) - [zh-HK](https://longbridge.com/zh-HK/news/257868601.md) generator: "portal-rs" --- # YZYBIO-B: Wang Tao elected as employee representative supervisor According to the announcement from Zhitong Finance APP, YZYBIO-B (02496) announced that Mr. Zhang Jing has resigned from his position as the employee representative supervisor of the company for personal career development reasons, effective from September 18, 2025. Dr. Wang Tao, Executive Director of the R&D Platform Department, was democratically elected as the employee representative supervisor of the second supervisory board on September 18, 2025. Dr. Wang Tao's term will be effective from September 18, 2025, and will expire at the end of the second supervisory board ### Related Stocks - [02496.HK](https://longbridge.com/en/quote/02496.HK.md) ## Related News & Research - [11:12 ETNarxoz Business School obtiene la prestigiosa acreditación conjunta de AMBA y BGA](https://longbridge.com/en/news/297934091.md) - [Innovent Biologics Grants Share Options and Restricted Shares Under 2024 Scheme](https://longbridge.com/en/news/297677279.md) - [Bessent heads to the G20 to rally allies on Iran as tariffs strain ties](https://longbridge.com/en/news/297462038.md) - [Innovent Biologics grants 583,731 restricted shares under 2024 share scheme](https://longbridge.com/en/news/297669209.md) - [HighTide Therapeutics Grants Performance-Linked Share Options and Awards](https://longbridge.com/en/news/297680846.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**